Atara Biotherapeutics, Inc.
ATRA
$14.10
$1.5512.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.57% | 61.28% | -67.43% | -36.75% | 90.38% |
| Total Receivables | -- | -- | 498.85% | 11.01% | -44.88% |
| Inventory | -- | -- | -- | -23.78% | -25.44% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.62% | -45.16% | -56.48% | 9.73% | 57.24% |
| Total Current Assets | -25.59% | -8.87% | -58.11% | -29.35% | 47.18% |
|
|
|||||
| Total Current Assets | -25.59% | -8.87% | -58.11% | -29.35% | 47.18% |
| Net Property, Plant & Equipment | -3.12% | -65.00% | -22.11% | -13.46% | -7.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.96% | -67.41% | -8.35% | -7.57% | -6.98% |
| Total Assets | -18.25% | -40.52% | -43.14% | -23.55% | 21.68% |
|
|
|||||
| Total Accounts Payable | -81.95% | 27.31% | -68.31% | 103.49% | -59.15% |
| Total Accrued Expenses | -42.97% | -46.10% | -21.65% | -7.15% | 6.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.89% | -83.89% | -0.01% | -5.06% | 4.71% |
| Total Finance Division Other Current Liabilities | 564.65% | -89.95% | -83.19% | -18.27% | 8.14% |
| Total Other Current Liabilities | 564.65% | -89.95% | -83.19% | -18.27% | 8.14% |
| Total Current Liabilities | 23.99% | -69.59% | -64.41% | -13.72% | 5.20% |
|
|
|||||
| Total Current Liabilities | 23.99% | -69.59% | -64.41% | -13.72% | 5.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.73% | -44.96% | -11.07% | -10.58% | -8.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.58% | 1.85% | 2.23% | -4.12% | 2.04% |
| Total Liabilities | -7.15% | -38.57% | -43.26% | -11.52% | 2.23% |
|
|
|||||
| Common Stock & APIC | 0.14% | 0.90% | 0.22% | 0.31% | 2.21% |
| Retained Earnings | -0.21% | 0.12% | 1.85% | -0.62% | -1.08% |
| Treasury Stock & Other | -- | -- | -- | -63.64% | 257.14% |
| Total Common Equity | -4.55% | 36.37% | 43.39% | -7.45% | 18.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.55% | 36.37% | 43.39% | -7.45% | 18.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.55% | 36.37% | 43.39% | -7.45% | 18.34% |
|
|
|||||